Albendazole-induced anagen effluvium: a brief literature review and our own experience.
Acta Dermatovenerol Alp Pannonica Adriat
; 29(3): 161-163, 2020 Sep.
Article
in En
| MEDLINE
| ID: mdl-32975305
ABSTRACT
Albendazole is a drug commonly used for treating many parasitoses. The primary mechanism of action is inhibition of microtubule polymerization binding to ß-tubulin, similar to colchicine as a microtubule formation inhibitor. It is reasonable that these two antimitotic drugs can cause side effects such as alopecia and cytopenia by a similar mechanism. In the literature, only one albendazole-induced anagen effluvium has been reported. This article presents two cases of anagen effluvium that developed 2 weeks after oral albendazole administration, summarizes all cases reported to date, and offers recommendations for a diagnostic approach.
Search on Google
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Albendazole
/
Alopecia Areata
/
Antiprotozoal Agents
Type of study:
Guideline
/
Systematic_reviews
Limits:
Adult
/
Child
/
Female
/
Humans
Language:
En
Journal:
Acta Dermatovenerol Alp Pannonica Adriat
Journal subject:
DERMATOLOGIA
/
DOENCAS SEXUALMENTE TRANSMISSIVEIS
Year:
2020
Document type:
Article
Affiliation country:
Turquía